M JAMES BARRETT Insider Trading $YMTX YUMANITY THERAPEUTICS, INC.
Get free email notifications about insider trading for M JAMES BARRETT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of M JAMES BARRETT. M JAMES BARRETT is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and Director in PHARMION CORP ($PHRM) and Director in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and Director in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and Director in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Liquidia Technologies Inc ($LQDA) and Director in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and Director in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and Director in Clovis Oncology, Inc. ($CLVS) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Epizyme, Inc. ($EPZM) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Zosano Pharma Corp ($ZSAN) and Director in Senseonics Holdings, Inc. ($SENS) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Surface Oncology, Inc. ($SURF).
M JAMES BARRETT in YUMANITY THERAPEUTICS, INC.
Trading Symbol: YMTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of M JAMES BARRETT: Director
Holdings: 5,554,610 shares
Current Value: $82,652,597
Latest Transaction: Jun 19 2018
$YMTX Market Capitalization: $367.66M
$YMTX Previous Close: $14.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of M JAMES BARRETT in YUMANITY THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, APPN, ARDM, ARDX, CRCM, CBIO, CERC, CLVS, EPZM, GLYC, HPTX, INHX, INWK, IOMI, ILIU, LIQDA, LOXO, MRSN, MULE, MYOG, PRTK, PHRM, RARX, RYTM, SENS, ROKA, SUPN, SURF, SYBX, TSRO, TCON, VTAE, VG, YMTX, ZSAN, ZHNE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2018 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | A | 3.19 | 15,300 | 48,807 | 15,300 | |
Dec 19 2017 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | P | 5.00 | 2,000,000 | 10,000,000 | 5,554,610 | 3.6 M to 5.6 M (+56.26 %) |
Aug 07 2017 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | A | 2.20 | 63,663 | 140,059 | 63,663 | |
Sep 15 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | P | 13.00 | 461,538 | 5,999,994 | 3,554,610 | 3.1 M to 3.6 M (+14.92 %) |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | C | 0.00 | 4,423,723 | 0 | 0 | |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | C | 0.00 | 13,848,000 | 0 | 0 | |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | P | 8.00 | 900,324 | 7,202,592 | 3,093,072 | 2.2 M to 3.1 M (+41.06 %) |
Feb 17 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Buy | C | 0.00 | 2,192,748 | 0 | 2,192,748 | 0 to 2.2 M |
Feb 12 2016 | PTI | PROTEOSTASIS THERA ... | BARRETT M JAMES | Director | Option Exercise | A | 8.00 | 45,760 | 366,080 | 45,760 |
Page: 1